William Blair Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-364,614
| Closed | -$98.8M | – | 424 |
|
|
2024
Q1 | $98.8M | Sell |
364,614
-5,989
| -2% | -$1.62M | 0.26% | 118 |
|
|
2023
Q4 | $87.6M | Sell |
370,603
-15,615
| -4% | -$3.69M | 0.26% | 115 |
|
|
2023
Q3 | $75.7M | Sell |
386,218
-8,041
| -2% | -$1.58M | 0.25% | 112 |
|
|
2023
Q2 | $82.9M | Sell |
394,259
-301,716
| -43% | -$63.4M | 0.27% | 110 |
|
|
2023
Q1 | $140M | Sell |
695,975
-14,045
| -2% | -$2.83M | 0.49% | 65 |
|
|
2022
Q4 | $155M | Sell |
710,020
-17,536
| -2% | -$3.82M | 0.59% | 53 |
|
|
2022
Q3 | $143M | Sell |
727,556
-277,643
| -28% | -$54.6M | 0.57% | 59 |
|
|
2022
Q2 | $215M | Sell |
1,005,199
-30,769
| -3% | -$6.58M | 0.8% | 27 |
|
|
2022
Q1 | $294M | Sell |
1,035,968
-40,282
| -4% | -$11.4M | 0.88% | 23 |
|
|
2021
Q4 | $406M | Buy |
1,076,250
+133,654
| +14% | +$50.4M | 1.1% | 10 |
|
|
2021
Q3 | $389M | Sell |
942,596
-35,882
| -4% | -$14.8M | 1.1% | 11 |
|
|
2021
Q2 | $362M | Sell |
978,478
-13,702
| -1% | -$5.07M | 1.14% | 13 |
|
|
2021
Q1 | $288M | Buy |
992,180
+861,234
| +658% | +$250M | 0.93% | 23 |
|
|
2020
Q4 | $32.7M | Sell |
130,946
-34,866
| -21% | -$8.71M | 0.11% | 164 |
|
|
2020
Q3 | $37.5M | Buy |
+165,812
| New | +$37.5M | 0.15% | 142 |
|
|
2018
Q3 | – | Sell |
-1,671,909
| Closed | -$188M | – | 438 |
|
|
2018
Q2 | $188M | Sell |
1,671,909
-36,614
| -2% | -$4.11M | 0.7% | 35 |
|
|
2018
Q1 | $182M | Buy |
1,708,523
+301,779
| +21% | +$32.2M | 0.7% | 38 |
|
|
2017
Q4 | $154M | Buy |
1,406,744
+1,361,626
| +3,018% | +$149M | 0.6% | 45 |
|
|
2017
Q3 | $4.87M | Buy |
+45,118
| New | +$4.87M | 0.02% | 356 |
|